Drug-Induced Peripheral Neuropathy: Diagnosis and Management

Curr Cancer Drug Targets. 2022;22(1):49-76. doi: 10.2174/1568009621666210720142542.

Abstract

Peripheral neuropathy comes in all shapes and forms and is a disorder which is found in the peripheral nervous system. It can have an acute or chronic onset depending on the multitude of pathophysiologic mechanisms involving different parts of nerve fibers. A systematic approach is highly beneficial when it comes to cost-effective diagnosis. More than 30 causes of peripheral neuropathy exist ranging from systemic and auto-immune diseases, vitamin deficiencies, viral infections, diabetes, etc. One of the major causes of peripheral neuropathy is drug-induced disease, which can be split into peripheral neuropathy caused by chemotherapy or by other medications. This review deals with the latest causes of drug-induced peripheral neuropathy, the population involved, the findings on physical examination and various workups needed and how to manage each case.

Keywords: Peripheral neuropathy; brentuximab; chemotherapy-induced; disulfiram; epithelones; eribulin; nitrous oxide; platinum drugs; proteasome inhibitors; suramin; taxanes; vinca alkaloids.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Humans
  • Peripheral Nervous System Diseases* / chemically induced
  • Peripheral Nervous System Diseases* / diagnosis
  • Peripheral Nervous System Diseases* / therapy

Substances

  • Antineoplastic Agents